New SLC22A12 (URAT1) Variant Associated with Renal Hypouricemia Identified by Whole-Exome Sequencing Analysis and Bioinformatics Predictions
Genes · 2023
DOI: 10.3390/genes14091823 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2023. Verfasst von Ana Perdomo-Ramírez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain. Hauptthemen laut MEDLINE: Renal Tubular Transport, Inborn Errors, Organic Anion Transporters. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion and the European Regional Development Fund “Another way to build….
Abstract (Originalsprache)
Renal hypouricemia (RHUC) is a rare hereditary disorder caused by loss-of-function mutations in the SLC22A12 (RHUC type 1) or SLC2A9 (RHUC type 2) genes, encoding urate transporters URAT1 and GLUT9, respectively, that reabsorb urate in the renal proximal tubule. The characteristics of this disorder are low serum urate levels, high renal fractional excretion of urate, and occasional severe complications such as nephrolithiasis and exercise-induced acute renal failure. In this study, we report two Spanish (Caucasian) siblings and a Pakistani boy with clinical characteristics compatible with RHUC. Whole-exome sequencing (WES) analysis identified two homozygous variants: a novel pathogenic SLC22A12 variant, c.1523G>A; p.(S508N), in the two Caucasian siblings and a previously reported SLC2A9 variant, c.646G>A; p.(G216R), in the Pakistani boy. Our findings suggest that these two mutations cause RHUC through loss of urate reabsorption and extend the SLC22A12 mutation spectrum. In addition, this work further emphasizes the importance of WES analysis in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.
- Departamento de Medicina Física y Farmacología, Facultad de Ciencias de la Salud, Sección Medicina, Universidad de La Laguna, 38071 Santa Cruz de Tenerife, Spain.
ORCID-Profile: Ana Perdomo-Ramírez, Félix Claverie-Martín
Förderung
- Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion and the European Regional Development Fund “Another way to build…
Zitieren
APA
Perdomo-Ramírez, A., Ramos-Trujillo, E., Claverie-Martín, F., & RenalTube Group (2023). New SLC22A12 (URAT1) Variant Associated with Renal Hypouricemia Identified by Whole-Exome Sequencing Analysis and Bioinformatics Predictions. Genes. https://doi.org/10.3390/genes14091823
Vancouver
Perdomo-Ramírez A, Ramos-Trujillo E, Claverie-Martín F, RenalTube Group. New SLC22A12 (URAT1) Variant Associated with Renal Hypouricemia Identified by Whole-Exome Sequencing Analysis and Bioinformatics Predictions. Genes. 2023. doi:10.3390/genes14091823
BibTeX
@article{PerdomoRamrez2023,
author = {Perdomo-Ramírez, Ana and Ramos-Trujillo, Elena and Claverie-Martín, Félix and RenalTube Group, RenalTube Group},
title = {New SLC22A12 (URAT1) Variant Associated with Renal Hypouricemia Identified by Whole-Exome Sequencing Analysis and Bioinformatics Predictions},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14091823}
}
EUVIMED